Baxter International Inc.

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX Other stock markets 13:41:36 2024-07-16 EDT			5-day change	1st Jan Change
34.8 ^USD	+2.44%		+1.68%	-10.55%

12:17pm	North American Morning Briefing : Retail Sales, -2-	DJ
07-15	Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says	MT

Baxter International plans to spin off kidney care units

January 06, 2023 at 07:24 am

(Reuters) - Medical device maker Baxter International Inc said on Friday it plans to spin off its kidney care units into an independent, publicly traded company in the next 12-18 months.

Baxter is also exploring alternatives for its BioPharma Solutions business, including a potential sale or other separation options, the company said.

(Reporting by Raghav Mahobe in Bengaluru; Editing by Shounak Dasgupta)

Latest news about Baxter International Inc.

North American Morning Briefing : Retail Sales, -2-	06:17am	DJ
Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says	07-15	MT
Morgan Stanley Downgrades Baxter International to Underweight From Equalweight, Cuts Price Target to $30 From $39	07-15	MT
Morgan Stanley Downgrades Baxter International to Underweight From Equalweight, Price Target is $30	07-15	MT
Citigroup Adjusts Price Target on Baxter International to $37 From $38	07-10	MT
Sector Update: Financial Stocks Advance Premarket Monday	07-08	MT
Sector Update: Financial	07-08	MT
That's not so bad, is it?	07-08
Stryker Corporation : Major Player in Medical Devices	07-05
Health Care Climbs After Baxter Deal - Health Care Roundup	07-05	DJ
S&P 500, Nasdaq Stretch Record Closing Runs After Jobs Data	07-05	MT
S&P 500, Nasdaq Stretch Record Closing Runs After Jobs Data	07-05	MT
Sector Update: Financial Stocks Ease Late Afternoon	07-05	MT
Sector Update: Financial	07-05	MT
Carlyle Group Reportedly in Advanced Talks to Buy Baxter's Vantive Business	07-05	CI
Carlyle Group in Advanced Talks to Acquire Vantive From Baxter	07-05	MT
Carlyle in talks to buy Baxter's kidney care unit, source says	07-05	RE
Carlyle in talks to acquire Baxter unit Vantive, WSJ reports	07-05	RE
Cerus Corporation Appoints Dean Gregory to its Board of Directors	07-02	CI
Evercore ISI Adjusts Price Target on Baxter International to $45 From $46, Maintains Outperform Rating	07-02	MT
Zimmer Biomet Holdings, Inc. Appoints Devdatt Kurdikar to its Board of Directors	06-20	CI
Transcript : Baxter International Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 08:40 AM	06-12
Transcript : Baxter International Inc. Presents at Jefferies 2024 Global Healthcare Conference, Jun-05-2024 09:30 AM	06-05
Baxter International Inc. Announces New Data Showing Expanded Hemodialysis, Known as HDX Therapy	05-29	CI
Citigroup Adjusts Price Target on Baxter International to $38 From $44, Keeps Neutral Rating	05-22	MT

Chart Baxter International Inc.

Duration

Period

More charts

Baxter International Inc. specializes in the development, manufacturing and marketing of medical devices and medications intended for healthcare professionals. Net sales break down by family of products as follows: - medicines and medical devices (33.8%): products intended for treating hemophilia (substitution clotting factors) and immune deficiencies (multi-purpose immunoglobins), and used in intensive care (human albumin) and biosurgery (fibrin adhesive, surgical gel, bone substitutes, hemostatic compresses, etc.); - kidney dialysis drugs and equipment (30.1%); - systems for delivering medications and intravenous therapy (15.2%): used in the fields of anesthesia, oncology (chemotherapy and radiation), parenteral nutrition, etc.; - other (20.1%). Export accounts for 52.7% of net sales.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-24 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Baxter International Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

33.97 USD

Average target price

44.75 USD

Spread / Average Target

+31.73%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
BAXTER INTERNATIONAL INC.	-10.55%	17.31B
ABBOTT LABORATORIES	-6.60%	179B
MEDTRONIC PLC	-6.24%	98.84B
BECTON, DICKINSON AND COMPANY	-6.11%	65.34B
HOYA CORPORATION	+15.46%	45.41B
DEXCOM, INC.	-7.34%	44.94B
CENCORA, INC.	+9.75%	43.76B
METTLER-TOLEDO INTERNATIONAL, INC.	+13.18%	29.01B
TERUMO CORPORATION	+19.39%	25.65B
WEST PHARMACEUTICAL SERVICES, INC.	-6.91%	23.32B

Other Medical Equipment, Supplies & Distribution

Baxter International Inc.

Equities

BAX

US0718131099

Medical Equipment, Supplies & Distribution

Baxter International plans to spin off kidney care units

Latest news about Baxter International Inc.

Chart Baxter International Inc.

Company Profile

Income Statement Evolution

Ratings for Baxter International Inc.

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution